Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Clinical trial NCT07223983 · RECRUITING

Trial details

NCT number: NCT07223983
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder Weight Loss Bariatric Surgery Patients

Start date: 2026-03-06
Primary completion: 2026-10-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.